This paper is in the following e-collection/theme issue:

Mobile Apps for Cancer Care and Cancer Prevention and Screening (265) Patient-Reported Outcome Measures (PROMs) (372) Cancer Survivorship (334) Usability of Apps and User Perceptions of mHealth (1188) Mobile Health (mhealth) (3461) Doctor-Patient Communication on Cancer, Prevention, and Screening (78) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1730) Design and Usability of Consumer Health Tech and Home Monitoring Devices (325) Focus Groups and Qualitative Research for Human Factors Research (1218) Innovations and Technology in Cancer Care (531) Participatory Cancer Care (119) Palliative Care (37)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/57388, first published .
Perceptions and Needs of Stakeholders Regarding MyPal Project’s Electronic Patient-Reported Outcome App: Cross-Sectional Qualitative Focus Group Study

Perceptions and Needs of Stakeholders Regarding MyPal Project’s Electronic Patient-Reported Outcome App: Cross-Sectional Qualitative Focus Group Study

Perceptions and Needs of Stakeholders Regarding MyPal Project’s Electronic Patient-Reported Outcome App: Cross-Sectional Qualitative Focus Group Study

Authors of this article:

Dimitrios Kyrou1 Author Orcid Image ;   Panos Bonotis1 Author Orcid Image ;   Christine Kakalou1 Author Orcid Image ;   Maria Vasilopoulou1 Author Orcid Image ;   Lydia Scarfò2 Author Orcid Image ;   Marcel Meyerheim3 Author Orcid Image ;   Annette Sander4 Author Orcid Image ;   Tomáš Arpáš5 Author Orcid Image ;   Eleni Kazantzaki6 Author Orcid Image ;   Christos Maramis1 Author Orcid Image ;   Christina Karamanidou1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Dimitrios Kyrou   1 * , MSc ;   Panos Bonotis   1 * , DipEng ;   Christine Kakalou   1 , MSc ;   Maria Vasilopoulou   1 , MSc ;   Lydia Scarfò   2 , MD ;   Marcel Meyerheim   3 , MSc ;   Annette Sander   4 , MD, PhD ;   Tomáš Arpáš   5 , MD ;   Eleni Kazantzaki   6 , MSc ;   Christos Maramis   1 , PhD ;   Christina Karamanidou   1 , PhD

1 Institute of Applied Biosciences, Centre for Research and Technology-Hellas, Thessaloniki, Greece

2 Strategic Research Program on Chronic lymphocytic leukemia, Division of Experimental Oncology, Università Vita Salute San Raffaele, Milano, Italy

3 Clinic of Pediatric Oncology and Hematology, Faculty of Medicine, Saarland University Hospital, Homburg, Germany

4 Clinic for Paediatric Oncology and Haematology, Hannover Medical School, Hannover, Germany

5 Department of Internal Medicine – Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic

6 Department of Hematology, University Hospital of Heraklion, Heraklion, Greece

*these authors contributed equally

Corresponding Author:

  • Christine Kakalou, MSc
  • Institute of Applied Biosciences
  • Centre for Research and Technology-Hellas
  • 6th Km. Charilaou-Thermi Road, Thermi
  • Thessaloniki 57001
  • Greece
  • Phone: 30 231125753
  • Email: ckakalou@certh.gr